Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Chronic Obstructive Pulmonary Disease|December 31, 2013
Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary diseaseCaitlyn T Solem, Shawn X Sun, Lavanya Sudharshan, et al.The Journal of Allergy and Clinical Immunology. in Practice|September 16, 2018
Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-AnalysisThomas B Casale, Maud Pacou, Laura Mesana, et al.International Journal of Chronic Obstructive Pulmonary Disease|November 16, 2012
Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationMargaret K Pasquale, Shawn X Sun, Frank Song, et al.Digestive Diseases and Sciences|March 8, 2011
Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness SurveyShawn X Sun, Marco Dibonaventura, Fanta W Purayidathil, et al.International Journal of Chronic Obstructive Pulmonary Disease|October 7, 2014
Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient surveyCaitlyn T Solem, Shawn X Sun, Sizhu Liu, et al.Immunotherapy|November 6, 2019
Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysisKevin Yan, Chakrapani Balijepalli, Rohini Sharma, et al.Journal of Medical Economics|October 14, 2011
Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPDShawn X Sun, Maryna Marynchenko, Ritesh Banerjee, et al.Respiratory Medicine|June 29, 2013
Development and validation of a claims-based prediction model for COPD severityDendy Macaulay, Shawn X Sun, Rachael A Sorg, et al.International Journal of Chronic Obstructive Pulmonary Disease|July 15, 2014
Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trialsStephen I Rennard, Shawn X Sun, Stavros Tourkodimitris, et al.Advances in Therapy|June 4, 2025
Disease Burden and Treatment Patterns Amongst Patients with Haemophilia A in China: A Retrospective Database Analysis StudyXuewen Song, Feng Xue, Lingling Chen, et al.Pageof 4